Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

Adults with COPD who used inhaled corticosteroids for more than 24 months faced higher risks for diabetes, osteoporosis, ...

The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease , are the fifth-leading cause of ...

Climate change is affecting the health of all individuals and represents an even more significant health risk for individuals with COPD.

People with asthma, chronic obstructive pulmonary disease (COPD), and certain other respiratory conditions typically receive Medicare coverage for inhalers. To receive coverage, a person must have ...

With Medicare coverage, a person can still have certain out-of-pocket costs for an inhaler. Out-of-pocket cost: This is the amount a person must pay for care when Medicare does not pay the total ...

The Hailie Smartinhaler device has also been cleared for use with inhalers from other manufacturers ... sells the device directly to patients with asthma and COPD under a 510(k) over-the-counter ...

Triple therapy inhalers are expected to account for 11.3% of the total market. The chronic obstructive pulmonary disease ...